partnershipHOOKIPA bags US$10m cancer milestoneLatest News HOOKIPA has received a US$10m milestone under its 2022 agreement with Roche to develop an arenaviral immunotherapy for KRAS-mutated cancers. Read more 14 February 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/Hookipa_T-Cell-Dendritic-Cell_interaction_V4_f2896ae796.jpeg 480 1600 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-02-14 10:17:012024-07-15 13:00:22HOOKIPA bags US$10m cancer milestone